10-year performance of four models of breast cancer risk: a validation study

The Lancet Oncology
Mary B TerryRobert J MacInnis

Abstract

Independent validation is essential to justify use of models of breast cancer risk prediction and inform decisions about prevention options and screening. Few independent validations had been done using cohorts for common breast cancer risk prediction models, and those that have been done had small sample sizes and short follow-up periods, and used earlier versions of the prediction tools. We aimed to validate the relative performance of four commonly used models of breast cancer risk and assess the effect of limited data input on each one's performance. In this validation study, we used the Breast Cancer Prospective Family Study Cohort (ProF-SC), which includes 18 856 women from Australia, Canada, and the USA who did not have breast cancer at recruitment, between March 17, 1992, and June 29, 2011. We selected women from the cohort who were 20-70 years old and had no previous history of bilateral prophylactic mastectomy or ovarian cancer, at least 2 months of follow-up data, and information available about family history of breast cancer. We used this selected cohort to calculate 10-year risk scores and compare four models of breast cancer risk prediction: the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimat...Continue Reading

Citations

Jun 30, 2019·International Journal of Cancer. Journal International Du Cancer·Adam R BrentnallDafydd Gareth R Evans
Nov 13, 2019·AJR. American Journal of Roentgenology·Cindy S LeeLinda Moy
Sep 27, 2019·Journal of the National Cancer Institute·Anne Marie McCarthyKevin S Hughes
Sep 27, 2019·Journal of the National Cancer Institute·Mitchel H Gail
Oct 5, 2019·Journal of the National Cancer Institute·Robert J MacInnisMary Beth Terry
Jun 6, 2019·Journal of the National Cancer Institute·Parichoy Pal ChoudhuryMontserrat Garcia-Closas
Jun 20, 2020·Nature Reviews. Clinical Oncology·Nora PashayanMartin Widschwendter
Jul 7, 2020·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Inge M M LakemanPeter Devilee
Dec 20, 2019·JNCI Cancer Spectrum·Kelly-Anne PhillipsUNKNOWN kConFab Investigators
Jun 13, 2020·Nature Reviews. Cancer·Kara L BrittKelly-Anne Phillips
Feb 20, 2020·International Journal of Environmental Research and Public Health·Hannah Lui Park
Sep 26, 2020·Nature Reviews. Clinical Oncology·Ophira GinsburgPaul Brennan
Feb 11, 2020·Frontiers in Oncology·Håkan Lars Olsson, Mona Landin Olsson
Sep 15, 2020·JCO Precision Oncology·Elisha HughesMark Robson
May 28, 2020·Obstetrics and Gynecology·David ChelmowJulia Sage O'Hara
Oct 21, 2020·Genes, Chromosomes & Cancer·Steffen HirschChristian P Schaaf
Dec 11, 2020·Neuroscience and Biobehavioral Reviews·E EeltinkJ J Luykx
Jan 21, 2021·The New England Journal of Medicine·Chunling HuFergus J Couch
Dec 11, 2020·Journal of the National Cancer Institute·Robert J MacInnisMary Beth Terry
Mar 24, 2021·International Journal of Epidemiology·Amber N HursonUNKNOWN B-CAST Risk Modelling Group
Apr 2, 2021·American Society of Clinical Oncology Educational Book·Marte C LiefaardLajos Pusztai
Dec 6, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Bernard RosnerGraham A Colditz
Mar 30, 2021·Journal of Breast Imaging·Geunwon Kim, Manisha Bahl
Apr 4, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Parisa TehranifarMary Beth Terry
May 13, 2021·JNCI Cancer Spectrum·Sherly X LiRobert J MacInnis
Oct 9, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R PalmerLudovic Trinquart
Aug 20, 2021·Molecular Oncology·Jacob K KresovichJack A Taylor
Jan 15, 2022·Nature Medicine·Nehmat Houssami, Karla Kerlikowske

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2022 Meta ULC. All rights reserved